BMT 101: The basics of allogeneic hematopoietic cell transplantation

Webinar lead by Dr Ivan Pasic on January 24, 2024 Dr. Ivan Pasic, FRCPC
About the speaker:
Dr. Pasic is a staff physician and clinician investigator in the Hans Messner Allogeneic Transplant Program at Princess Margaret Hospital. He obtained his MD and PhD degrees in 2012 and subsequently completed residencies in internal medicine and medical oncology in 2016 and 2017 at the University of Toronto. He went on to complete a fellowship in allogeneic hematopoietic cell transplantation in the Hans Messner Allogeneic Transplant Program in 2019. During his fellowship, he served as the chief transplant and malignant hematology fellow physician during the 2018-2019 academic year. Throughout his career he always had a keen interest in research. The work on his doctoral thesis on biomarker discovery in paediatric cancers was published in Cancer Research. His current basic science research interest is in the characterization of factors influencing transplant-related complications such as graft-vs-host disease and relapse. He recently published a study describing the discovery of novel biomarkers of acute graft-vs-host disease in allogeneic hematopoietic transplant recipients. On the clinical side, Dr. Pasic focuses on the characterization of factors impacting transplant-related complications, with a particular emphasis on the use of novel conditioning regimens designed to reduce transplantation-related mortality. He is an author on over 50 peer-reviewed studies. He is a sitting member on the institutional Oncology Research Ethics Board. During COVID-19 pandemic, he was a member of the Princess Margaret Hospital COVID-19 Vaccine Guidance Committee, which released institutional evidence-based guidance to vaccination of oncology patients against SARS-CoV-2.